Outcomes of Elderly Patients with Esophageal Cancer

The incidence of oesophageal cancer in populations aged 65 and above is rising globally, reflecting demographic ageing and disease epidemiology. Treatment decisions in this group must balance potential survival benefits against heightened risks of morbidity and loss of autonomy. Surgical resection, notably oesophagectomy, remains the cornerstone of curative intent but carries substantial perioperative risks that increase with comorbidities and physiological reserve. Definitive and neoadjuvant chemoradiotherapy offer alternative or adjunctive strategies, demonstrating comparable survival in selected cohorts while avoiding operative stress. Patient selection increasingly emphasises frailty over chronological age, with structured assessments guiding therapeutic intensity. Recent predictive models integrating clinical, radiological and laboratory data have enhanced individualised planning, estimating objective response rates and progression-free survival. While postoperative mortality and complication rates remain higher in the elderly, careful preoperative evaluation, modern minimally invasive techniques and enhanced recovery protocols have narrowed the gap. Definitive non-operative approaches yield promising outcomes, particularly for squamous cell histology, albeit with distinct toxicity profiles. Overall, mounting evidence supports that age alone should not preclude curative therapies; instead, a nuanced approach incorporating comorbidity, functional status and patient preferences optimises outcomes.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Outcomes of Elderly Patients with Esophageal Cancer publication trend

The graph below shows the total number of articles in outcomes of elderly patients with esophageal cancer across all publications each year (not limited to Nature Index journals).

Technical terms

Esophagectomy: Surgical removal of all or part of the oesophagus.

Chemoradiotherapy: Combined administration of chemotherapy and radiotherapy.

Frailty Index: Composite score reflecting physiological reserve and vulnerability to stress.

Nomogram: Graphical tool integrating multiple predictors to estimate individual outcome probabilities.

Objective Response Rate (ORR): Proportion of patients achieving a predefined reduction in tumour size.

Progression-Free Survival (PFS): Interval during which disease does not worsen following treatment.

References

1. Individualized treatment decision model for inoperable elderly esophageal squamous cell carcinoma based on multi-modal data fusion. BMC Medical Informatics and Decision Making (2023).
2. A Novel Frailty Index Can Predict the Short-Term Outcomes of Esophagectomy in Older Patients with Esophageal Cancer. Current Oncology (2024).
3. Esophageal Cancer in Elderly Patients, Current Treatment Options and Outcomes; A Systematic Review and Pooled Analysis. Cancers (2021).